80 Mg Degarelix For Injection

Name: 80 Mg Degarelix For Injection
Brand: NEETCO BIOPHARMA
Price: 7000 INR
Availability: InStock

Price 7000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

80 Mg Degarelix For Injection Specification

Pacakaging (Quantity Per Box)
1 vial per box

Indication
Advanced Prostate Cancer

Origin of Medicine
Imported/Allopathic

Salt Composition
Degarelix 80 mg

Dosage Form
Injection

Drug Type
Allopathic

Ingredients
Degarelix Acetate

Physical Form
Lyophilized Powder for Injection

Function
Gonadotropin-Releasing Hormone (GnRH) antagonist for management of advanced prostate cancer

Recommended For
Prostate Cancer patients

Dosage
80 mg via subcutaneous injection

Dosage Guidelines
As directed by the healthcare provider

Suitable For
Adults

Quantity
80 mg vial

Storage Instructions
Store at 2C-8C (Refrigerated). Do not freeze.

About 80 Mg Degarelix For Injection

Degarelix 80 mg for injection is a top-tier, cost-effective solution for advanced prostate cancer treatment. This world-class GnRH antagonist, presented as a white to off-white lyophilized powder, requires reconstitution with the provided solvent before use. Highly regarded for its valiant action and remarkable efficacy, it is preservative-free and suitable for adult administration via subcutaneous injection. Degarelix offers a bargain for distributors and suppliers, ensuring market-leading performance with a 2-year shelf life. Each box contains one vial, making it a reliable, allopathic choice for professionals across India and global markets.

Reliable and Safe Therapeutic Solution

Degarelix 80 mg for injection stands out with its advanced formulation using high-purity Degarelix Acetate. Its precise dosage and preservative-free nature guarantee top safety standards. Administered subcutaneously, this lyophilized powder for injection ensures rapid and sustained therapeutic action against advanced prostate cancer. Suitable only for adults, it adheres to stringent regulatory guidelines, offering a consistent, reliable, and valiant approach for healthcare professionals seeking cost-effective, top-tier cancer therapy.

Extensive Market Reach and Quality Certifications

Widely recognized in global and national markets, Degarelix 80 mg for injection boasts exceptional logistics support and goods transport reliability. Its robust presence in major export markets and strategic domestic distribution maximizes market value for distributors and traders in India. Each shipment adheres to certified manufacturing and regulatory standards, ensuring world-class quality and compliance. This injection remains a dependable choice for those prioritizing quality and efficient delivery in oncological care.

FAQ's of 80 Mg Degarelix For Injection:

Q: How should Degarelix 80 mg for injection be administered?

A: Degarelix 80 mg should be administered via subcutaneous injection, following reconstitution with the provided solvent. The process must be performed under the supervision of a qualified healthcare professional as per prescription guidelines.

Q: What is the therapeutic benefit of using Degarelix injection?

A: Degarelix acts as a Gonadotropin-Releasing Hormone (GnRH) antagonist, effectively managing advanced prostate cancer by rapidly reducing testosterone levels, thereby inhibiting the growth of cancer cells.

Q: When is Degarelix indicated for patients?

A: Degarelix is indicated for adult patients diagnosed with advanced prostate cancer, where hormonal therapy is advised by a healthcare provider.

Q: Where should Degarelix 80 mg vials be stored?

A: The vials must be stored in a refrigerated environment between 2C and 8C. They should never be frozen to maintain their efficacy.

Q: What is the process for preparing Degarelix 80 mg for administration?

A: Preparation involves reconstituting the white to off-white lyophilized powder with the supplied solvent before use. The injection should only be given after proper mixing and verification by a healthcare professional.